AIM
AIM ImmunoTech Inc.
AIM ImmunoTech Inc. insider trading
Insiders at AIM ImmunoTech Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Equels Thomas K (CEO & President · Director) buying $1.3K of AIM, filed Sep 15, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $1.3K
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 14, 2026
From SEC filings · last 30 days
Recent AIM insider transactions
Equels Thomas KCEO & President · Director
Bought 5,900 sh at $0.22 · Sep 14, 2026
$1.3K
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
AIM insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 5 insiders traded AIM on the open market: 19 purchases worth $212.4K and 1 sale worth $870. In the last four quarters alone: no open-market trades at all.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | — | — | |
| Q4 2025 | — | — | |
| Q3 2025 | — | — | |
| Q2 2025 | +$128.2K7 buys | — | |
| Q1 2025 | +$21.8K3 buys | — | |
| Q4 2024 | +$54.7K7 buys | −$8701 sale | |
| Q3 2024 | +$7.7K2 buys | — |
- Largest purchase
- +$59.1K of AIM by Equels Thomas K (CEO & President · Director) on Apr 11, 2025.
- Largest sale
- −$870 of AIM by Mitchell William M (Director) on Dec 19, 2024.
Open-market transactions through Jun 30, 2026most recent first
Equels Thomas K
CEO & President · Director
+$824
Jun 13, 2025
107 sh · $7.70
Equels Thomas K
CEO & President · Director
+$896
Jun 12, 2025
103 sh · $8.70
Equels Thomas K
CEO & President · Director
+$59.1K
Apr 11, 2025
1,968,500 sh · $0.03
Kellner Ted D
Director
+$59.1K
Apr 11, 2025
1,968,500 sh · $0.03
Mitchell William M
Director
+$5.9K
Apr 11, 2025
196,867 sh · $0.03
Equels Thomas K
CEO & President · Director
+$2.5K
Apr 04, 2025
41,000 sh · $0.06
Rodino Peter W III
COO, Secretary, Gen. Counsel
+$45
Apr 04, 2025
500 sh · $0.09
Equels Thomas K
CEO & President · Director
+$6.5K
Mar 05, 2025
50,000 sh · $0.13
Equels Thomas K
CEO & President · Director
+$10K
Mar 04, 2025
83,333 sh · $0.12
Equels Thomas K
CEO & President · Director
+$5.3K
Mar 04, 2025
44,000 sh · $0.12
Mitchell William M
Director
−$870
Dec 19, 2024
4,579 sh · $0.19
Equels Thomas K
CEO & President · Director
+$4.8K
Dec 18, 2024
22,729 sh · $0.21
Appelrouth Stewart
Director
+$2.3K
Dec 02, 2024
11,110 sh · $0.21
Appelrouth Stewart
Director
+—
Dec 02, 2024
0.0000 sh · $0.21
Equels Thomas K
CEO & President · Director
+$4.2K
Nov 21, 2024
20,000 sh · $0.21
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 13, 2025 | Equels Thomas KCEO & President · Director | 107 | $7.70 | +$824 |
| Jun 12, 2025 | Equels Thomas KCEO & President · Director | 103 | $8.70 | +$896 |
| Apr 11, 2025 | Equels Thomas KCEO & President · Director | 1,968,500 | $0.03 | +$59.1K |
| Apr 11, 2025 | Kellner Ted DDirector | 1,968,500 | $0.03 | +$59.1K |
| Apr 11, 2025 | Mitchell William MDirector | 196,867 | $0.03 | +$5.9K |
| Apr 04, 2025 | Equels Thomas KCEO & President · Director | 41,000 | $0.06 | +$2.5K |
| Apr 04, 2025 | Rodino Peter W IIICOO, Secretary, Gen. Counsel | 500 | $0.09 | +$45 |
| Mar 05, 2025 | Equels Thomas KCEO & President · Director | 50,000 | $0.13 | +$6.5K |
| Mar 04, 2025 | Equels Thomas KCEO & President · Director | 83,333 | $0.12 | +$10K |
| Mar 04, 2025 | Equels Thomas KCEO & President · Director | 44,000 | $0.12 | +$5.3K |
| Dec 19, 2024 | Mitchell William MDirector | 4,579 | $0.19 | −$870 |
| Dec 18, 2024 | Equels Thomas KCEO & President · Director | 22,729 | $0.21 | +$4.8K |
| Dec 02, 2024 | Appelrouth StewartDirector | 11,110 | $0.21 | +$2.3K |
| Dec 02, 2024 | Appelrouth StewartDirector | 0.0000 | $0.21 | +— |
| Nov 21, 2024 | Equels Thomas KCEO & President · Director | 20,000 | $0.21 | +$4.2K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check AIM — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
AIM ImmunoTech Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are AIM insiders buying or selling?
- Between Sep 14, 2026 and Sep 14, 2026, 1 AIM ImmunoTech Inc. insider made 1 open-market purchase worth $1.3K and no sales, a net purchase of $1.3K.
- How much AIM stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 5 AIM ImmunoTech Inc. insiders made 19 open-market purchases worth $212.4K and 1 sale worth $870. In the four quarters to Jun 30, 2026: no purchases and no sales. The largest purchase was Equels Thomas K buying $59.1K on Apr 11, 2025. The largest sale was Mitchell William M selling $870 on Dec 19, 2024.
- What was the largest recent AIM insider trade?
- Equels Thomas K (CEO & President · Director) bought $1.3K of AIM stock on Sep 14, 2026 at about $0.22 a share.
- When did an insider last buy AIM shares?
- The most recent open-market purchase on file is Equels Thomas K (CEO & President · Director) buying $1.3K on Sep 14, 2026.
- Where does AIM insider trading data come from?
- From the Form 4 filings AIM ImmunoTech Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.